United Therapeutics Chairperson and CEO Martine Rothblatt disposes of 8,500 common shares worth $4.45 million
UTHR•Insider transaction details
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $135.42 on Aug. 11.
- The related trust sold 8,500 shares the same day at prices ranging from about $513.37 to $531.01.
- Holdings in that trust fell to 324,443 shares following the transactions.
